Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Executive Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Hypoxic-ischemic encephalopathy
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Trofinetide Published Studies & Presentations
Rett Syndrome
NNZ-2591Published Studies & Presentations
Phelan-McDermid Syndrome
Pitt Hopkins Syndrome
Angelman Syndrome
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Feb 18, 2008
Form 604
Feb 13, 2008
Becoming a substantial holder
Feb 11, 2008
Change of Director's Interest Notice
Feb 11, 2008
Change of Director's Interest Notice
Feb 11, 2008
Rights issue raises $7.1m and notes convert
Feb 11, 2008
Substantial shareholder notice
Feb 07, 2008
Change in substantial holding
Feb 07, 2008
Appendix 3B - shares issued on conversion of notes
Feb 07, 2008
Appendix 3B - allotment of rights issue underwriter shares
Feb 05, 2008
Notice under section 708A(5)(e)
Previous
1
2
3
4
5
6
Next
